Valens Sees Canaccord Cut Price Target After Investor Day

On February 7th, The Valens Company (TSX: VLNS) held its 2022 investor day. The company outlined in a news release where management speaks on the company’s strengths while announcing it has identified an additional $10 million of annual cost saving. This comes in the form of operation efficiencies, removal of underperforming SKU’s, automation, and contract growth.

A number of analysts lowered their 12-month price target on Valens after the investor day, bringing the average 12-month price target down to C$10.53, or a 313% upside to the current stock price. There are currently 7 analysts covering the stock with 1 analyst having a strong buy rating, 5 have buys and 1 analyst has a hold rating on the stock. The street high sits at C$15.75, which represents a 518% upside while the lowest price target comes in at $7.50 from two analysts.

In Canaccord Genuity’s note, they reiterate their speculative buy rating but lower their 12-month price target from C$11 to C$9, saying that they have lowered their full-year 2021 and 2022 estimates as the company gave an update on their operations and key objectives.

Canaccord notes that the most important takeaway from the investor day might have been management highlighting Valens transition from a white-label or processing company to a branded products company. Interestingly, Valens expects bankruptcies to leave roughly 25% of the market unaccounted for. For this reason, they expect that branded sales will be between 40% and 50% of their full-year sales in 2022 and beyond.

For the company’s U.S asset, Valens expects that between COVID pressures forcing the shutdown of many smaller CBD operators and a new e-commerce platform, they believe that the CBD sales to account for 25% to 35% of the company’s total 2022 sales.

Lastly, the company’s main focus on the financial side comes by promising cost-saving, as 2021 was a big M&A year for Valens. They additionally offered 2023 guidance as they expect revenue to be greater than C$225 million with greater than 10% EBITDA margins. The company also added that growth might slow due to softer B2B sales and the elimination of toll processing.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Silver47 Completes Property-Wide Geochemical, Rock Sampling Program At Adams Plateau, Identifies Numerous Targets

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Related News

MicroStrategy: Canaccord Initiates With $920 Price Target

On Friday, Canaccord Genuity initiated coverage on MicroStrategy (NASDAQ: MSTR) with a $920 price target...

Monday, April 12, 2021, 04:03:00 PM

Haywood Initiates On Bragg Gaming With $3.00 Price Target

Earlier this week, Haywood Capital Markets initiated coverage on Bragg Gaming (TSX: BRAG) with a...

Wednesday, April 28, 2021, 03:21:00 PM

Verano: Canaccord Drops Price Target After Revenue Miss

On November 16th, Verano Holdings (CSE: VRNO) announced its third quarter financial results. The company...

Thursday, November 18, 2021, 11:44:00 AM

Salesforce: Analysts Maintain Ratings Following Slack Acquisition Announcement

On December 1st, Salesforce.com (NYSE: CRM) announced a definitive agreement to buy Slack (NYSE: WORK)...

Thursday, December 3, 2020, 02:31:00 PM

Were Traders Tipped Off About Maxar’s Buyout?

On December 16, Maxar Technologies (TSX: MAXR) announced that it would be acquired by Advent...

Friday, December 23, 2022, 06:24:00 AM